Anavex Life Sciences Corp (AVXL)

[falconer66a]

Nope. Not likely.

Maybe the Amyloid buildup thesis(root Cause of AD) will finally get the factual assessment it needs.

Well, the factual assessment data continue to accumulate, which coupled with the abject failure of all of the amyloid treatments for the last two or three decades should seal the deal.

But, it won’t. Dozens of researchers and drug company managers have bought into and spent their entire careers parked on the amyloid etiology thesis. To turn away from it will be to admit professional error, reflecting scientific incompetence. These people spent years and tens of thousands of dollars getting their MD or PhD degrees. No other group knows what they know; they must be listened to. They possess the accepted, respected knowledge on what, certainly, must cause Alzheimer’s. Their research has appeared in all of the major medical research journals, with peer and editorial reviews.

So, no, I don’t expect any turn-away from the amyloid hypothesis until blarcamesine has been on the market for several years and, finally, millions with Alzheimer’s finally gain relief.

In the medical history books, it will be an additional chapter, showing how, of all professions, medicine most adheres to “accepted knowledge,” resisting utterly new perspectives and therapeutic approaches. It took a half-century to get the germ theory accepted as the cause of disease; the reigning medical poobahs had to first die off. It was known that diseases are caused by the unhealthful re-breathing of stale air at night. Pasteur and Lister were on-the-edge medical weirdos, with goofy ideas. Like Missling, et al.